ピペラシリン＆タゾバクタムAPIのグローバル市場インサイト・予測（～2027年）

• 英文タイトル：Global Piperacillin and Tazobactam API Market Insights and Forecast to 2027

• レポートコード：QY2112C00826
• 出版社/出版日：QYResearch / 2021年12月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、114ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査資料はピペラシリン＆タゾバクタムAPIの世界市場の現状について調査・分析し、2027年までの市場を予測しました。ピペラシリン＆タゾバクタムAPIの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（ピペラシリン、タゾバクタム）、用途別市場規模（注入、合成注入）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・ピペラシリン＆タゾバクタムAPIの世界市場概要
・メーカー別の競争状況、市場シェア
・ピペラシリン＆タゾバクタムAPIの種類別市場規模：ピペラシリン、タゾバクタム
・ピペラシリン＆タゾバクタムAPIの用途別市場規模：注入、合成注入
・北米のピペラシリン＆タゾバクタムAPI市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ）
・ヨーロッパのピペラシリン＆タゾバクタムAPI市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス）
・アジアのピペラシリン＆タゾバクタムAPI市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国）
・中南米のピペラシリン＆タゾバクタムAPI市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル）
・中東・アフリカのピペラシリン＆タゾバクタムAPI市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア）
・企業情報：Qilu Pharmaceutical、Pﬁzer Healthcare、Fresenius Kabi、Aurobindo Pharma、Sandoz、NCPC、REYOUNG、Yuhan Corporation、LKPC、Nectar Lifesciences、Sterile India、Suanfarma、Rajasthan Antibiotics
・ピペラシリン＆タゾバクタムAPIのバリューチェーン・販売チャネル分析
・ピペラシリン＆タゾバクタムAPIの世界市場動向

Piperacillin and tazobactam combination is an antibiotic that belongs to the group of medicines known as penicillins and beta-lactamase inhibitors

Market Analysis and Insights: Global Piperacillin and Tazobactam API Market
The global Piperacillin and Tazobactam API market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Piperacillin and Tazobactam API Scope and Segment
Piperacillin and Tazobactam API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Piperacillin and Tazobactam API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Piperacillin
Tazobactam

Segment by Application
Injection
Compound Injection

By Company
Qilu Pharmaceutical
Pﬁzer Healthcare
Fresenius Kabi
Aurobindo Pharma
Sandoz
NCPC
REYOUNG
Yuhan Corporation
LKPC
Nectar Lifesciences
Sterile India
Suanfarma
Rajasthan Antibiotics

Production by Region
North America
Europe
China
Japan

Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Piperacillin and Tazobactam API Product Introduction
1.2 Market by Type
1.2.1 Global Piperacillin and Tazobactam API Market Size Growth Rate by Type
1.2.2 Piperacillin
1.2.3 Tazobactam
1.3 Market by Application
1.3.1 Global Piperacillin and Tazobactam API Market Size Growth Rate by Application
1.3.2 Injection
1.3.3 Compound Injection
1.4 Study Objectives
1.5 Years Considered

2 Global Piperacillin and Tazobactam API Production
2.1 Global Piperacillin and Tazobactam API Production Capacity (2016-2027)
2.2 Global Piperacillin and Tazobactam API Production by Region: 2016 VS 2021 VS 2027
2.3 Global Piperacillin and Tazobactam API Production by Region
2.3.1 Global Piperacillin and Tazobactam API Historic Production by Region (2016-2021)
2.3.2 Global Piperacillin and Tazobactam API Forecasted Production by Region (2022-2027)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan

3 Global Piperacillin and Tazobactam API Sales in Volume & Value Estimates and Forecasts
3.1 Global Piperacillin and Tazobactam API Sales Estimates and Forecasts 2016-2027
3.2 Global Piperacillin and Tazobactam API Revenue Estimates and Forecasts 2016-2027
3.3 Global Piperacillin and Tazobactam API Revenue by Region: 2016 VS 2021 VS 2027
3.4 Global Top Piperacillin and Tazobactam API Regions by Sales
3.4.1 Global Top Piperacillin and Tazobactam API Regions by Sales (2016-2021)
3.4.2 Global Top Piperacillin and Tazobactam API Regions by Sales (2022-2027)
3.5 Global Top Piperacillin and Tazobactam API Regions by Revenue
3.5.1 Global Top Piperacillin and Tazobactam API Regions by Revenue (2016-2021)
3.5.2 Global Top Piperacillin and Tazobactam API Regions by Revenue (2022-2027)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa

4 Competition by Manufactures
4.1 Global Piperacillin and Tazobactam API Production Capacity by Manufacturers
4.2 Global Piperacillin and Tazobactam API Sales by Manufacturers
4.2.1 Global Top Piperacillin and Tazobactam API Manufacturers by Sales (2016-2021)
4.2.2 Global Top Piperacillin and Tazobactam API Manufacturers Market Share by Sales (2016-2021)
4.2.3 Global Top 10 and Top 5 Companies by Piperacillin and Tazobactam API Sales in 2020
4.3 Global Piperacillin and Tazobactam API Revenue by Manufacturers
4.3.1 Global Top Piperacillin and Tazobactam API Manufacturers by Revenue (2016-2021)
4.3.2 Global Top Piperacillin and Tazobactam API Manufacturers Market Share by Revenue (2016-2021)
4.3.3 Global Top 10 and Top 5 Companies by Piperacillin and Tazobactam API Revenue in 2020
4.4 Global Piperacillin and Tazobactam API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Piperacillin and Tazobactam API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Piperacillin and Tazobactam API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type
5.1 Global Piperacillin and Tazobactam API Sales by Type
5.1.1 Global Piperacillin and Tazobactam API Historical Sales by Type (2016-2021)
5.1.2 Global Piperacillin and Tazobactam API Forecasted Sales by Type (2022-2027)
5.1.3 Global Piperacillin and Tazobactam API Sales Market Share by Type (2016-2027)
5.2 Global Piperacillin and Tazobactam API Revenue by Type
5.2.1 Global Piperacillin and Tazobactam API Historical Revenue by Type (2016-2021)
5.2.2 Global Piperacillin and Tazobactam API Forecasted Revenue by Type (2022-2027)
5.2.3 Global Piperacillin and Tazobactam API Revenue Market Share by Type (2016-2027)
5.3 Global Piperacillin and Tazobactam API Price by Type
5.3.1 Global Piperacillin and Tazobactam API Price by Type (2016-2021)
5.3.2 Global Piperacillin and Tazobactam API Price Forecast by Type (2022-2027)

6 Market Size by Application
6.1 Global Piperacillin and Tazobactam API Sales by Application
6.1.1 Global Piperacillin and Tazobactam API Historical Sales by Application (2016-2021)
6.1.2 Global Piperacillin and Tazobactam API Forecasted Sales by Application (2022-2027)
6.1.3 Global Piperacillin and Tazobactam API Sales Market Share by Application (2016-2027)
6.2 Global Piperacillin and Tazobactam API Revenue by Application
6.2.1 Global Piperacillin and Tazobactam API Historical Revenue by Application (2016-2021)
6.2.2 Global Piperacillin and Tazobactam API Forecasted Revenue by Application (2022-2027)
6.2.3 Global Piperacillin and Tazobactam API Revenue Market Share by Application (2016-2027)
6.3 Global Piperacillin and Tazobactam API Price by Application
6.3.1 Global Piperacillin and Tazobactam API Price by Application (2016-2021)
6.3.2 Global Piperacillin and Tazobactam API Price Forecast by Application (2022-2027)

7 North America
7.1 North America Piperacillin and Tazobactam API Market Size by Type
7.1.1 North America Piperacillin and Tazobactam API Sales by Type (2016-2027)
7.1.2 North America Piperacillin and Tazobactam API Revenue by Type (2016-2027)
7.2 North America Piperacillin and Tazobactam API Market Size by Application
7.2.1 North America Piperacillin and Tazobactam API Sales by Application (2016-2027)
7.2.2 North America Piperacillin and Tazobactam API Revenue by Application (2016-2027)
7.3 North America Piperacillin and Tazobactam API Sales by Country
7.3.1 North America Piperacillin and Tazobactam API Sales by Country (2016-2027)
7.3.2 North America Piperacillin and Tazobactam API Revenue by Country (2016-2027)
7.3.3 United States
7.3.4 Canada

8 Europe
8.1 Europe Piperacillin and Tazobactam API Market Size by Type
8.1.1 Europe Piperacillin and Tazobactam API Sales by Type (2016-2027)
8.1.2 Europe Piperacillin and Tazobactam API Revenue by Type (2016-2027)
8.2 Europe Piperacillin and Tazobactam API Market Size by Application
8.2.1 Europe Piperacillin and Tazobactam API Sales by Application (2016-2027)
8.2.2 Europe Piperacillin and Tazobactam API Revenue by Application (2016-2027)
8.3 Europe Piperacillin and Tazobactam API Sales by Country
8.3.1 Europe Piperacillin and Tazobactam API Sales by Country (2016-2027)
8.3.2 Europe Piperacillin and Tazobactam API Revenue by Country (2016-2027)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia

9 Asia Pacific
9.1 Asia Pacific Piperacillin and Tazobactam API Market Size by Type
9.1.1 Asia Pacific Piperacillin and Tazobactam API Sales by Type (2016-2027)
9.1.2 Asia Pacific Piperacillin and Tazobactam API Revenue by Type (2016-2027)
9.2 Asia Pacific Piperacillin and Tazobactam API Market Size by Application
9.2.1 Asia Pacific Piperacillin and Tazobactam API Sales by Application (2016-2027)
9.2.2 Asia Pacific Piperacillin and Tazobactam API Revenue by Application (2016-2027)
9.3 Asia Pacific Piperacillin and Tazobactam API Sales by Region
9.3.1 Asia Pacific Piperacillin and Tazobactam API Sales by Region (2016-2027)
9.3.2 Asia Pacific Piperacillin and Tazobactam API Revenue by Region (2016-2027)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia

10 Latin America
10.1 Latin America Piperacillin and Tazobactam API Market Size by Type
10.1.1 Latin America Piperacillin and Tazobactam API Sales by Type (2016-2027)
10.1.2 Latin America Piperacillin and Tazobactam API Revenue by Type (2016-2027)
10.2 Latin America Piperacillin and Tazobactam API Market Size by Application
10.2.1 Latin America Piperacillin and Tazobactam API Sales by Application (2016-2027)
10.2.2 Latin America Piperacillin and Tazobactam API Revenue by Application (2016-2027)
10.3 Latin America Piperacillin and Tazobactam API Sales by Country
10.3.1 Latin America Piperacillin and Tazobactam API Sales by Country (2016-2027)
10.3.2 Latin America Piperacillin and Tazobactam API Revenue by Country (2016-2027)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Piperacillin and Tazobactam API Market Size by Type
11.1.1 Middle East and Africa Piperacillin and Tazobactam API Sales by Type (2016-2027)
11.1.2 Middle East and Africa Piperacillin and Tazobactam API Revenue by Type (2016-2027)
11.2 Middle East and Africa Piperacillin and Tazobactam API Market Size by Application
11.2.1 Middle East and Africa Piperacillin and Tazobactam API Sales by Application (2016-2027)
11.2.2 Middle East and Africa Piperacillin and Tazobactam API Revenue by Application (2016-2027)
11.3 Middle East and Africa Piperacillin and Tazobactam API Sales by Country
11.3.1 Middle East and Africa Piperacillin and Tazobactam API Sales by Country (2016-2027)
11.3.2 Middle East and Africa Piperacillin and Tazobactam API Revenue by Country (2016-2027)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE

12 Corporate Profiles
12.1 Qilu Pharmaceutical
12.1.1 Qilu Pharmaceutical Corporation Information
12.1.2 Qilu Pharmaceutical Overview
12.1.3 Qilu Pharmaceutical Piperacillin and Tazobactam API Sales, Price, Revenue and Gross Margin (2016-2021)
12.1.4 Qilu Pharmaceutical Piperacillin and Tazobactam API Product Description
12.1.5 Qilu Pharmaceutical Recent Developments
12.2 Pﬁzer Healthcare
12.2.1 Pﬁzer Healthcare Corporation Information
12.2.2 Pﬁzer Healthcare Overview
12.2.3 Pﬁzer Healthcare Piperacillin and Tazobactam API Sales, Price, Revenue and Gross Margin (2016-2021)
12.2.4 Pﬁzer Healthcare Piperacillin and Tazobactam API Product Description
12.2.5 Pﬁzer Healthcare Recent Developments
12.3 Fresenius Kabi
12.3.1 Fresenius Kabi Corporation Information
12.3.2 Fresenius Kabi Overview
12.3.3 Fresenius Kabi Piperacillin and Tazobactam API Sales, Price, Revenue and Gross Margin (2016-2021)
12.3.4 Fresenius Kabi Piperacillin and Tazobactam API Product Description
12.3.5 Fresenius Kabi Recent Developments
12.4 Aurobindo Pharma
12.4.1 Aurobindo Pharma Corporation Information
12.4.2 Aurobindo Pharma Overview
12.4.3 Aurobindo Pharma Piperacillin and Tazobactam API Sales, Price, Revenue and Gross Margin (2016-2021)
12.4.4 Aurobindo Pharma Piperacillin and Tazobactam API Product Description
12.4.5 Aurobindo Pharma Recent Developments
12.5 Sandoz
12.5.1 Sandoz Corporation Information
12.5.2 Sandoz Overview
12.5.3 Sandoz Piperacillin and Tazobactam API Sales, Price, Revenue and Gross Margin (2016-2021)
12.5.4 Sandoz Piperacillin and Tazobactam API Product Description
12.5.5 Sandoz Recent Developments
12.6 NCPC
12.6.1 NCPC Corporation Information
12.6.2 NCPC Overview
12.6.3 NCPC Piperacillin and Tazobactam API Sales, Price, Revenue and Gross Margin (2016-2021)
12.6.4 NCPC Piperacillin and Tazobactam API Product Description
12.6.5 NCPC Recent Developments
12.7 REYOUNG
12.7.1 REYOUNG Corporation Information
12.7.2 REYOUNG Overview
12.7.3 REYOUNG Piperacillin and Tazobactam API Sales, Price, Revenue and Gross Margin (2016-2021)
12.7.4 REYOUNG Piperacillin and Tazobactam API Product Description
12.7.5 REYOUNG Recent Developments
12.8 Yuhan Corporation
12.8.1 Yuhan Corporation Corporation Information
12.8.2 Yuhan Corporation Overview
12.8.3 Yuhan Corporation Piperacillin and Tazobactam API Sales, Price, Revenue and Gross Margin (2016-2021)
12.8.4 Yuhan Corporation Piperacillin and Tazobactam API Product Description
12.8.5 Yuhan Corporation Recent Developments
12.9 LKPC
12.9.1 LKPC Corporation Information
12.9.2 LKPC Overview
12.9.3 LKPC Piperacillin and Tazobactam API Sales, Price, Revenue and Gross Margin (2016-2021)
12.9.4 LKPC Piperacillin and Tazobactam API Product Description
12.9.5 LKPC Recent Developments
12.10 Nectar Lifesciences
12.10.1 Nectar Lifesciences Corporation Information
12.10.2 Nectar Lifesciences Overview
12.10.3 Nectar Lifesciences Piperacillin and Tazobactam API Sales, Price, Revenue and Gross Margin (2016-2021)
12.10.4 Nectar Lifesciences Piperacillin and Tazobactam API Product Description
12.10.5 Nectar Lifesciences Recent Developments
12.11 Sterile India
12.11.1 Sterile India Corporation Information
12.11.2 Sterile India Overview
12.11.3 Sterile India Piperacillin and Tazobactam API Sales, Price, Revenue and Gross Margin (2016-2021)
12.11.4 Sterile India Piperacillin and Tazobactam API Product Description
12.11.5 Sterile India Recent Developments
12.12 Suanfarma
12.12.1 Suanfarma Corporation Information
12.12.2 Suanfarma Overview
12.12.3 Suanfarma Piperacillin and Tazobactam API Sales, Price, Revenue and Gross Margin (2016-2021)
12.12.4 Suanfarma Piperacillin and Tazobactam API Product Description
12.12.5 Suanfarma Recent Developments
12.13 Rajasthan Antibiotics
12.13.1 Rajasthan Antibiotics Corporation Information
12.13.2 Rajasthan Antibiotics Overview
12.13.3 Rajasthan Antibiotics Piperacillin and Tazobactam API Sales, Price, Revenue and Gross Margin (2016-2021)
12.13.4 Rajasthan Antibiotics Piperacillin and Tazobactam API Product Description
12.13.5 Rajasthan Antibiotics Recent Developments

13 Industry Chain and Sales Channels Analysis
13.1 Piperacillin and Tazobactam API Industry Chain Analysis
13.2 Piperacillin and Tazobactam API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Piperacillin and Tazobactam API Production Mode & Process
13.4 Piperacillin and Tazobactam API Sales and Marketing
13.4.1 Piperacillin and Tazobactam API Sales Channels
13.4.2 Piperacillin and Tazobactam API Distributors
13.5 Piperacillin and Tazobactam API Customers

14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Piperacillin and Tazobactam API Industry Trends
14.2 Piperacillin and Tazobactam API Market Drivers
14.3 Piperacillin and Tazobactam API Market Challenges
14.4 Piperacillin and Tazobactam API Market Restraints

15 Key Finding in The Global Piperacillin and Tazobactam API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Piperacillin and Tazobactam API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Piperacillin
Table 3. Major Manufacturers of Tazobactam
Table 4. Global Piperacillin and Tazobactam API Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Piperacillin and Tazobactam API Production by Region: 2016 VS 2021 VS 2027 (Kiloton)
Table 6. Global Piperacillin and Tazobactam API Production by Region (2016-2021) & (Kiloton)
Table 7. Global Piperacillin and Tazobactam API Production Market Share by Region (2016-2021)
Table 8. Global Piperacillin and Tazobactam API Production by Region (2022-2027) & (Kiloton)
Table 9. Global Piperacillin and Tazobactam API Production Market Share by Region (2022-2027)
Table 10. Global Piperacillin and Tazobactam API Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Piperacillin and Tazobactam API Sales by Region (2016-2021) & (Kiloton)
Table 12. Global Piperacillin and Tazobactam API Sales Market Share by Region (2016-2021)
Table 13. Global Piperacillin and Tazobactam API Sales by Region (2022-2027) & (Kiloton)
Table 14. Global Piperacillin and Tazobactam API Sales Market Share by Region (2022-2027)
Table 15. Global Piperacillin and Tazobactam API Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Piperacillin and Tazobactam API Revenue Market Share by Region (2016-2021)
Table 17. Global Piperacillin and Tazobactam API Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Piperacillin and Tazobactam API Revenue Market Share by Region (2022-2027)
Table 19. Global Piperacillin and Tazobactam API Production Capacity by Manufacturers (2016-2021) & (Kiloton)
Table 20. Global Piperacillin and Tazobactam API Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Piperacillin and Tazobactam API Production by Manufacturers (2016-2021) & (Kiloton)
Table 22. Global Piperacillin and Tazobactam API Production Market Share by Manufacturers (2016-2021)
Table 23. Global Piperacillin and Tazobactam API Sales by Manufacturers (2016-2021) & (Kiloton)
Table 24. Global Piperacillin and Tazobactam API Sales Share by Manufacturers (2016-2021)
Table 25. Global Piperacillin and Tazobactam API Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Piperacillin and Tazobactam API Revenue Share by Manufacturers (2016-2021)
Table 27. Piperacillin and Tazobactam API Price by Manufacturers 2016-2021 (US$/Ton)
Table 28. Global Piperacillin and Tazobactam API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Piperacillin and Tazobactam API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Piperacillin and Tazobactam API as of 2020)
Table 30. Piperacillin and Tazobactam API Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Piperacillin and Tazobactam API Product Offered
Table 32. Date of Manufacturers Enter into Piperacillin and Tazobactam API Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Piperacillin and Tazobactam API Sales by Type (2016-2021) & (Kiloton)
Table 35. Global Piperacillin and Tazobactam API Sales by Type (2022-2027) & (Kiloton)
Table 36. Global Piperacillin and Tazobactam API Sales Share by Type (2016-2021)
Table 37. Global Piperacillin and Tazobactam API Sales Share by Type (2022-2027)
Table 38. Global Piperacillin and Tazobactam API Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Piperacillin and Tazobactam API Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Piperacillin and Tazobactam API Revenue Share by Type (2016-2021)
Table 41. Global Piperacillin and Tazobactam API Revenue Share by Type (2022-2027)
Table 42. Piperacillin and Tazobactam API Price by Type (2016-2021) & (US$/Ton)
Table 43. Global Piperacillin and Tazobactam API Price Forecast by Type (2022-2027) & (US$/Ton)
Table 44. Global Piperacillin and Tazobactam API Sales by Application (2016-2021) & (Kiloton)
Table 45. Global Piperacillin and Tazobactam API Sales by Application (2022-2027) & (Kiloton)
Table 46. Global Piperacillin and Tazobactam API Sales Share by Application (2016-2021)
Table 47. Global Piperacillin and Tazobactam API Sales Share by Application (2022-2027)
Table 48. Global Piperacillin and Tazobactam API Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Piperacillin and Tazobactam API Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Piperacillin and Tazobactam API Revenue Share by Application (2016-2021)
Table 51. Global Piperacillin and Tazobactam API Revenue Share by Application (2022-2027)
Table 52. Piperacillin and Tazobactam API Price by Application (2016-2021) & (US$/Ton)
Table 53. Global Piperacillin and Tazobactam API Price Forecast by Application (2022-2027) & (US$/Ton)
Table 54. North America Piperacillin and Tazobactam API Sales by Type (2016-2021) & (Kiloton)
Table 55. North America Piperacillin and Tazobactam API Sales by Type (2022-2027) & (Kiloton)
Table 56. North America Piperacillin and Tazobactam API Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Piperacillin and Tazobactam API Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Piperacillin and Tazobactam API Sales by Application (2016-2021) & (Kiloton)
Table 59. North America Piperacillin and Tazobactam API Sales by Application (2022-2027) & (Kiloton)
Table 60. North America Piperacillin and Tazobactam API Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Piperacillin and Tazobactam API Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Piperacillin and Tazobactam API Sales by Country (2016-2021) & (Kiloton)
Table 63. North America Piperacillin and Tazobactam API Sales by Country (2022-2027) & (Kiloton)
Table 64. North America Piperacillin and Tazobactam API Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Piperacillin and Tazobactam API Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Piperacillin and Tazobactam API Sales by Type (2016-2021) & (Kiloton)
Table 67. Europe Piperacillin and Tazobactam API Sales by Type (2022-2027) & (Kiloton)
Table 68. Europe Piperacillin and Tazobactam API Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Piperacillin and Tazobactam API Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Piperacillin and Tazobactam API Sales by Application (2016-2021) & (Kiloton)
Table 71. Europe Piperacillin and Tazobactam API Sales by Application (2022-2027) & (Kiloton)
Table 72. Europe Piperacillin and Tazobactam API Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Piperacillin and Tazobactam API Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Piperacillin and Tazobactam API Sales by Country (2016-2021) & (Kiloton)
Table 75. Europe Piperacillin and Tazobactam API Sales by Country (2022-2027) & (Kiloton)
Table 76. Europe Piperacillin and Tazobactam API Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Piperacillin and Tazobactam API Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Piperacillin and Tazobactam API Sales by Type (2016-2021) & (Kiloton)
Table 79. Asia Pacific Piperacillin and Tazobactam API Sales by Type (2022-2027) & (Kiloton)
Table 80. Asia Pacific Piperacillin and Tazobactam API Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Piperacillin and Tazobactam API Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Piperacillin and Tazobactam API Sales by Application (2016-2021) & (Kiloton)
Table 83. Asia Pacific Piperacillin and Tazobactam API Sales by Application (2022-2027) & (Kiloton)
Table 84. Asia Pacific Piperacillin and Tazobactam API Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Piperacillin and Tazobactam API Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Piperacillin and Tazobactam API Sales by Region (2016-2021) & (Kiloton)
Table 87. Asia Pacific Piperacillin and Tazobactam API Sales by Region (2022-2027) & (Kiloton)
Table 88. Asia Pacific Piperacillin and Tazobactam API Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Piperacillin and Tazobactam API Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Piperacillin and Tazobactam API Sales by Type (2016-2021) & (Kiloton)
Table 91. Latin America Piperacillin and Tazobactam API Sales by Type (2022-2027) & (Kiloton)
Table 92. Latin America Piperacillin and Tazobactam API Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Piperacillin and Tazobactam API Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Piperacillin and Tazobactam API Sales by Application (2016-2021) & (Kiloton)
Table 95. Latin America Piperacillin and Tazobactam API Sales by Application (2022-2027) & (Kiloton)
Table 96. Latin America Piperacillin and Tazobactam API Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Piperacillin and Tazobactam API Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Piperacillin and Tazobactam API Sales by Country (2016-2021) & (Kiloton)
Table 99. Latin America Piperacillin and Tazobactam API Sales by Country (2022-2027) & (Kiloton)
Table 100. Latin America Piperacillin and Tazobactam API Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Piperacillin and Tazobactam API Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Piperacillin and Tazobactam API Sales by Type (2016-2021) & (Kiloton)
Table 103. Middle East and Africa Piperacillin and Tazobactam API Sales by Type (2022-2027) & (Kiloton)
Table 104. Middle East and Africa Piperacillin and Tazobactam API Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Piperacillin and Tazobactam API Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Piperacillin and Tazobactam API Sales by Application (2016-2021) & (Kiloton)
Table 107. Middle East and Africa Piperacillin and Tazobactam API Sales by Application (2022-2027) & (Kiloton)
Table 108. Middle East and Africa Piperacillin and Tazobactam API Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Piperacillin and Tazobactam API Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Piperacillin and Tazobactam API Sales by Country (2016-2021) & (Kiloton)
Table 111. Middle East and Africa Piperacillin and Tazobactam API Sales by Country (2022-2027) & (Kiloton)
Table 112. Middle East and Africa Piperacillin and Tazobactam API Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Piperacillin and Tazobactam API Revenue by Country (2022-2027) & (US$ Million)
Table 114. Qilu Pharmaceutical Corporation Information
Table 115. Qilu Pharmaceutical Description and Major Businesses
Table 116. Qilu Pharmaceutical Piperacillin and Tazobactam API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 117. Qilu Pharmaceutical Piperacillin and Tazobactam API Product
Table 118. Qilu Pharmaceutical Recent Development
Table 119. Pﬁzer Healthcare Corporation Information
Table 120. Pﬁzer Healthcare Description and Major Businesses
Table 121. Pﬁzer Healthcare Piperacillin and Tazobactam API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 122. Pﬁzer Healthcare Piperacillin and Tazobactam API Product
Table 123. Pﬁzer Healthcare Recent Development
Table 124. Fresenius Kabi Corporation Information
Table 125. Fresenius Kabi Description and Major Businesses
Table 126. Fresenius Kabi Piperacillin and Tazobactam API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 127. Fresenius Kabi Piperacillin and Tazobactam API Product
Table 128. Fresenius Kabi Recent Development
Table 129. Aurobindo Pharma Corporation Information
Table 130. Aurobindo Pharma Description and Major Businesses
Table 131. Aurobindo Pharma Piperacillin and Tazobactam API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 132. Aurobindo Pharma Piperacillin and Tazobactam API Product
Table 133. Aurobindo Pharma Recent Development
Table 134. Sandoz Corporation Information
Table 135. Sandoz Description and Major Businesses
Table 136. Sandoz Piperacillin and Tazobactam API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 137. Sandoz Piperacillin and Tazobactam API Product
Table 138. Sandoz Recent Development
Table 139. NCPC Corporation Information
Table 140. NCPC Description and Major Businesses
Table 141. NCPC Piperacillin and Tazobactam API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 142. NCPC Piperacillin and Tazobactam API Product
Table 143. NCPC Recent Development
Table 144. REYOUNG Corporation Information
Table 145. REYOUNG Description and Major Businesses
Table 146. REYOUNG Piperacillin and Tazobactam API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 147. REYOUNG Piperacillin and Tazobactam API Product
Table 148. REYOUNG Recent Development
Table 149. Yuhan Corporation Corporation Information
Table 150. Yuhan Corporation Description and Major Businesses
Table 151. Yuhan Corporation Piperacillin and Tazobactam API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 152. Yuhan Corporation Piperacillin and Tazobactam API Product
Table 153. Yuhan Corporation Recent Development
Table 154. LKPC Corporation Information
Table 155. LKPC Description and Major Businesses
Table 156. LKPC Piperacillin and Tazobactam API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 157. LKPC Piperacillin and Tazobactam API Product
Table 158. LKPC Recent Development
Table 159. Nectar Lifesciences Corporation Information
Table 160. Nectar Lifesciences Description and Major Businesses
Table 161. Nectar Lifesciences Piperacillin and Tazobactam API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 162. Nectar Lifesciences Piperacillin and Tazobactam API Product
Table 163. Nectar Lifesciences Recent Development
Table 164. Sterile India Corporation Information
Table 165. Sterile India Description and Major Businesses
Table 166. Sterile India Piperacillin and Tazobactam API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 167. Sterile India Piperacillin and Tazobactam API Product
Table 168. Sterile India Recent Development
Table 169. Suanfarma Corporation Information
Table 170. Suanfarma Description and Major Businesses
Table 171. Suanfarma Piperacillin and Tazobactam API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 172. Suanfarma Piperacillin and Tazobactam API Product
Table 173. Suanfarma Recent Development
Table 174. Rajasthan Antibiotics Corporation Information
Table 175. Rajasthan Antibiotics Description and Major Businesses
Table 176. Rajasthan Antibiotics Piperacillin and Tazobactam API Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 177. Rajasthan Antibiotics Piperacillin and Tazobactam API Product
Table 178. Rajasthan Antibiotics Recent Development
Table 179. Key Raw Materials Lists
Table 180. Raw Materials Key Suppliers Lists
Table 181. Piperacillin and Tazobactam API Distributors List
Table 182. Piperacillin and Tazobactam API Customers List
Table 183. Piperacillin and Tazobactam API Market Trends
Table 184. Piperacillin and Tazobactam API Market Drivers
Table 185. Piperacillin and Tazobactam API Market Challenges
Table 186. Piperacillin and Tazobactam API Market Restraints
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Piperacillin and Tazobactam API Product Picture
Figure 2. Global Piperacillin and Tazobactam API Market Share by Type in 2020 & 2027
Figure 3. Piperacillin Product Picture
Figure 4. Tazobactam Product Picture
Figure 5. Global Piperacillin and Tazobactam API Market Share by Application in 2020 & 2027
Figure 6. Injection
Figure 7. Compound Injection
Figure 8. Piperacillin and Tazobactam API Report Years Considered
Figure 9. Global Piperacillin and Tazobactam API Capacity, Production and Utilization (2016-2027) & (Kiloton)
Figure 10. Global Piperacillin and Tazobactam API Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 11. Global Piperacillin and Tazobactam API Production Market Share by Region (2016-2021)
Figure 12. Global Piperacillin and Tazobactam API Production Market Share by Region (2022-2027)
Figure 13. Piperacillin and Tazobactam API Production Growth Rate in North America (2016-2027) & (Kiloton)
Figure 14. Piperacillin and Tazobactam API Production Growth Rate in Europe (2016-2027) & (Kiloton)
Figure 15. Piperacillin and Tazobactam API Production Growth Rate in China (2016-2027) & (Kiloton)
Figure 16. Piperacillin and Tazobactam API Production Growth Rate in Japan (2016-2027) & (Kiloton)
Figure 17. Global Piperacillin and Tazobactam API Sales 2016-2027 (Kiloton)
Figure 18. Global Piperacillin and Tazobactam API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Piperacillin and Tazobactam API Revenue 2016-2027 (US$ Million)
Figure 20. Global Piperacillin and Tazobactam API Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 21. Global Piperacillin and Tazobactam API Sales Market Share by Region (2016-2021)
Figure 22. Global Piperacillin and Tazobactam API Sales Market Share by Region (2022-2027)
Figure 23. North America Piperacillin and Tazobactam API Sales YoY (2016-2027) & (Kiloton)
Figure 24. North America Piperacillin and Tazobactam API Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Europe Piperacillin and Tazobactam API Sales YoY (2016-2027) & (Kiloton)
Figure 26. Europe Piperacillin and Tazobactam API Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Asia-Pacific Piperacillin and Tazobactam API Sales YoY (2016-2027) & (Kiloton)
Figure 28. Asia-Pacific Piperacillin and Tazobactam API Revenue YoY (2016-2027) & (US$ Million)
Figure 29. Latin America Piperacillin and Tazobactam API Sales YoY (2016-2027) & (Kiloton)
Figure 30. Latin America Piperacillin and Tazobactam API Revenue YoY (2016-2027) & (US$ Million)
Figure 31. Middle East & Africa Piperacillin and Tazobactam API Sales YoY (2016-2027) & (Kiloton)
Figure 32. Middle East & Africa Piperacillin and Tazobactam API Revenue YoY (2016-2027) & (US$ Million)
Figure 33. The Top 10 and Top 5 Players Market Share by Piperacillin and Tazobactam API Sales in 2020
Figure 34. The Top 10 and Top 5 Players Market Share by Piperacillin and Tazobactam API Revenue in 2020
Figure 35. Piperacillin and Tazobactam API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 36. Global Piperacillin and Tazobactam API Sales Market Share by Type (2016-2027)
Figure 37. Global Piperacillin and Tazobactam API Revenue Market Share by Type (2016-2027)
Figure 38. Global Piperacillin and Tazobactam API Sales Market Share by Application (2016-2027)
Figure 39. Global Piperacillin and Tazobactam API Revenue Market Share by Application (2016-2027)
Figure 40. North America Piperacillin and Tazobactam API Sales Market Share by Type (2016-2027)
Figure 41. North America Piperacillin and Tazobactam API Revenue Market Share by Type (2016-2027)
Figure 42. North America Piperacillin and Tazobactam API Sales Market Share by Application (2016-2027)
Figure 43. North America Piperacillin and Tazobactam API Revenue Market Share by Application (2016-2027)
Figure 44. North America Piperacillin and Tazobactam API Sales Share by Country (2016-2027)
Figure 45. North America Piperacillin and Tazobactam API Revenue Share by Country (2016-2027)
Figure 46. United States Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 47. Canada Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 48. Europe Piperacillin and Tazobactam API Sales Market Share by Type (2016-2027)
Figure 49. Europe Piperacillin and Tazobactam API Revenue Market Share by Type (2016-2027)
Figure 50. Europe Piperacillin and Tazobactam API Sales Market Share by Application (2016-2027)
Figure 51. Europe Piperacillin and Tazobactam API Revenue Market Share by Application (2016-2027)
Figure 52. Europe Piperacillin and Tazobactam API Sales Share by Country (2016-2027)
Figure 53. Europe Piperacillin and Tazobactam API Revenue Share by Country (2016-2027)
Figure 54. Germany Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 55. France Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 56. U.K. Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 57. Italy Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 58. Russia Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 59. Asia Pacific Piperacillin and Tazobactam API Sales Market Share by Type (2016-2027)
Figure 60. Asia Pacific Piperacillin and Tazobactam API Revenue Market Share by Type (2016-2027)
Figure 61. Asia Pacific Piperacillin and Tazobactam API Sales Market Share by Application (2016-2027)
Figure 62. Asia Pacific Piperacillin and Tazobactam API Revenue Market Share by Application (2016-2027)
Figure 63. Asia Pacific Piperacillin and Tazobactam API Sales Share by Region (2016-2027)
Figure 64. Asia Pacific Piperacillin and Tazobactam API Revenue Share by Region (2016-2027)
Figure 65. China Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 66. Japan Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 67. South Korea Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 68. India Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 69. Australia Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 70. China Taiwan Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 71. Indonesia Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 72. Thailand Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 73. Malaysia Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 74. Latin America Piperacillin and Tazobactam API Sales Market Share by Type (2016-2027)
Figure 75. Latin America Piperacillin and Tazobactam API Revenue Market Share by Type (2016-2027)
Figure 76. Latin America Piperacillin and Tazobactam API Sales Market Share by Application (2016-2027)
Figure 77. Latin America Piperacillin and Tazobactam API Revenue Market Share by Application (2016-2027)
Figure 78. Latin America Piperacillin and Tazobactam API Sales Share by Country (2016-2027)
Figure 79. Latin America Piperacillin and Tazobactam API Revenue Share by Country (2016-2027)
Figure 80. Mexico Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 81. Brazil Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 82. Argentina Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 83. Middle East and Africa Piperacillin and Tazobactam API Sales Market Share by Type (2016-2027)
Figure 84. Middle East and Africa Piperacillin and Tazobactam API Revenue Market Share by Type (2016-2027)
Figure 85. Middle East and Africa Piperacillin and Tazobactam API Sales Market Share by Application (2016-2027)
Figure 86. Middle East and Africa Piperacillin and Tazobactam API Revenue Market Share by Application (2016-2027)
Figure 87. Middle East and Africa Piperacillin and Tazobactam API Sales Share by Country (2016-2027)
Figure 88. Middle East and Africa Piperacillin and Tazobactam API Revenue Share by Country (2016-2027)
Figure 89. Turkey Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 90. Saudi Arabia Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 91. UAE Piperacillin and Tazobactam API Revenue (2016-2027) & (US$ Million)
Figure 92. Piperacillin and Tazobactam API Value Chain
Figure 93. Piperacillin and Tazobactam API Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed

以下、関連資料のご紹介

ピペラシリンナトリウムAPIのグローバル市場インサイト・予測（～2027年）

Global Piperacillin Sodium API Market Insights and Forecast to 2027
QY2112C00827 2021年12月 107Pages
本調査資料はピペラシリンナトリウムAPIの世界市場の現状について調査・分析し、2027年までの市場を予測しました。ピペラシリンナトリウムAPIの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（ピペラシリン、ピペラシリン、タゾバクタム）、用途別市場規模（注入、合成注入）、主要地域別市場...

テルル化モリブデンスパッタリングターゲットのグローバル市場インサイト・予測（～2027年）

Global Molybdenum Telluride Sputtering Target Market Insights and Forecast to 2027
QY2112C00525 2021年12月 109Pages
本調査資料はテルル化モリブデンスパッタリングターゲットの世界市場の現状について調査・分析し、2027年までの市場を予測しました。テルル化モリブデンスパッタリングターゲットの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度99％、純度99.5％、純度99.9％、純度99.95％、純...

オゾン酸化触媒のグローバル市場インサイト・予測（～2027年）

Global Ozone Oxidation Catalyst Market Insights and Forecast to 2027
QY2112C00721 2021年12月 101Pages
本調査資料はオゾン酸化触媒の世界市場の現状について調査・分析し、2027年までの市場を予測しました。オゾン酸化触媒の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（セラムサイト/粘土、活性炭、活性アルミナ、シリコンアルミニウム複合材料）、用途別市場規模（ケミカルパーク処理、都市下水処...

金属検出可能型シリコーンシートのグローバル市場インサイト・予測（～2027年）

Global Metal Detectable Silicone Sheets Market Insights and Forecast to 2027
QY2112C00442 2021年12月 127Pages
本調査資料は金属検出可能型シリコーンシートの世界市場の現状について調査・分析し、2027年までの市場を予測しました。金属検出可能型シリコーンシートの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（固体シリコーン、スポンジシリコーン）、用途別市場規模（食品・飲料、医薬品、その他）、主要...

フタロ顔料のグローバル市場インサイト・予測（～2027年）

Global Phthalo Pigment Market Insights and Forecast to 2027
QY2112C00820 2021年12月 126Pages
本調査資料はフタロ顔料の世界市場の現状について調査・分析し、2027年までの市場を予測しました。フタロ顔料の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（フタロブルー、フタログリーン）、用途別市場規模（塗料・コーティング剤、インク、プラスチック、その他）、主要地域別市場規模（北米・...

プラスチック包装袋のグローバル市場インサイト・予測（～2027年）

Global Plastic Packaging Bags Market Insights and Forecast to 2027
QY2112C00838 2021年12月 129Pages
本調査資料はプラスチック包装袋の世界市場の現状について調査・分析し、2027年までの市場を予測しました。プラスチック包装袋の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（PP、PE、その他）、用途別市場規模（食品産業、化学、農業、製薬、パーソナル＆ホームケア、その他）、主要地域別市...

液体リン酸塩のグローバル市場インサイト・予測（～2027年）

Global Liquid Phosphites Market Insights and Forecast to 2027
QY2112C00332 2021年12月 96Pages
本調査資料は液体リン酸塩の世界市場の現状について調査・分析し、2027年までの市場を予測しました。液体リン酸塩の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（DPDP、EHDP、PDDP、TNPP）、用途別市場規模（熱安定剤、酸化防止剤、その他）、主要地域別市場規模（北米・アメリカ...

AlベースCCL用球状アルミナのグローバル市場インサイト・予測（～2027年）

Global Spherical Alumina for Al Base CCL Market Insights and Forecast to 2027
QY2112C01239 2021年12月 95Pages
本調査資料はAlベースCCL用球状アルミナの世界市場の現状について調査・分析し、2027年までの市場を予測しました。AlベースCCL用球状アルミナの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（1〜5μm、5〜20μm、その他）、用途別市場規模（通信、家電、自動車、その他）、主要地...

硝酸スカンジウムのグローバル市場インサイト・予測（～2027年）

Global Scandium Nitrate Market Insights and Forecast to 2027
QY2112C01101 2021年12月 104Pages
本調査資料は硝酸スカンジウムの世界市場の現状について調査・分析し、2027年までの市場を予測しました。硝酸スカンジウムの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度99％、純度99.9％、純度99.99％、純度99.999％）、用途別市場規模（化学、実験室、工業、その他）、主...

オキシインドールのグローバル市場インサイト・予測（～2027年）

Global Oxindole Market Insights and Forecast to 2027
QY2112C00718 2021年12月 87Pages
本調査資料はオキシインドールの世界市場の現状について調査・分析し、2027年までの市場を予測しました。オキシインドールの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度98％、純度99％）、用途別市場規模（有機合成、医薬品中間体、その他）、主要地域別市場規模（北米・アメリカ、ヨー...

ピペラシリンナトリウムAPIのグローバル市場インサイト・予測（～2027年） Piperacillin Sodium is the sodium salt of piperacillin, a broad-spectrum semisynthetic, ampicillin-derived ureidopenicillin antibiotic with bactericidal activity. Piperacillin binds to and inactivates penicillin-binding proteins (PBPs), enzymes located on the inner membrane of the bacterial cell wal…
乳酸菌注射液のグローバル市場インサイト・予測（～2027年） Lactated Ringer’s Injection is a sterile, non-pyrogenic solution intended for fluid and electrolyte replenishment in single dose containers. May be administered intravenously, subcutaneously or intraperitoneally (except in horses) using aseptic technique. Market Analysis and Insights: Global Lactate…
テトラデシル硫酸ナトリウム注射のグローバル市場インサイト・予測（～2027年） Sodium Tetradecyl Sulfate Injection is a sclerosing agent. It works by increasing the formation of blood clots and scar tissue inside certain types of veins. This helps decrease dilation of enlarged veins. Market Analysis and Insights: Global Sodium Tetradecyl Sulfate Injection Market The global Sod…
注入済みワイプのグローバル市場インサイト・予測（～2027年） Pre-Injection Wipe acts as a disinfectant to clean and remove bacteria prior to administering an injection. Market Analysis and Insights: Global Pre-Injection Wipes Market The global Pre-Injection Wipes market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end …
LIM・LSR射出成形機のグローバル市場インサイト・予測（～2027年） Liquid injection molding, or LIM, is a manufacturing process commonly used to make rubber parts or to make parts that need to withstand extreme conditions, regardless of the industry. The process is an injection molding process at heart, meaning that materials are injected into a pre-made mold, wher…